1442 studies found for:    "Sexually Transmitted Diseases, Viral"
Show Display Options
Rank Status Study
21 Not yet recruiting Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia
Conditions: Chronic Hepatitis C;   Human Immunodeficiency Virus (HIV)
Intervention:
22 Recruiting Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals
Condition: AIDS-related Dementia Complex
Interventions: Drug: Darunavir;   Drug: ritonavir;   Drug: cobicistat
23 Not yet recruiting Inhalation/Nasal Corticosteroids and Prevalence of Hypothalamic-pituitary-adrenal (HPA) Axis Suppression in Human Immunodeficiency Virus (HIV)-Patients
Condition: Adrenal Insufficiency
Intervention: Other: ACTH stimulation test
24 Not yet recruiting Feasibility of Short-Term PrEP Uptake for MSM With Episodic High-Risk for HIV
Condition: Human Immunodeficiency Virus
Interventions: Drug: emtricitabine/tenofovir;   Behavioral: CBT-based counseling
25 Not yet recruiting A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in the Rilpivirine Pediatric Studies
Condition: Human Immunodeficiency Virus Type 1
Intervention: Drug: Rilpivirine
26 Active, not recruiting Mother and Infant Visit Adherence and Treatment Engagement Study
Condition: Human Immunodeficiency Virus
Interventions: Behavioral: cMM;   Behavioral: Text Messaging
27 Completed Study of Safety and Pharmacokinetics in Healthy Volunteers and Safety, Tolerability and Antiviral Activity of VM-1500 in Patients With Human Immunodeficiency Virus-1 Infection
Condition: HIV Infection
Intervention: Drug: VM-1500/Placebo
28 Recruiting CPAP Improving Mortality for Pneumonia in African Children Trial
Conditions: Pneumonia;   Human Immunodeficiency Virus (HIV);   Malnutrition
Intervention: Device: bubble continuous positive airway pressure (CPAP)
29 Recruiting Efficacy and Tolerability of Topical LFX453 for External Genital Warts
Condition: External Genital Warts
Interventions: Drug: LFX453;   Drug: Aldara®
30 Not yet recruiting First Event of Infection by HIV-1 of Uterine Vaginal Tissue
Condition: HIV Infection of the Uterine Vaginal Tissues
Intervention:
31 Recruiting Randomized Controlled Trial of Shang Ring Male Children Circumcision: Comparison Between Flip and No Flip Technique
Condition: Human Immunodeficiency Virus
Interventions: Device: No flip technique of Shang Ring circumcision;   Device: Flip technique of Shang Ring circumcision
32 Recruiting Efficacy and Safety of Sofosbuvir/GS-5816 Fixed Dose Combination for 12 Weeks in Adults With Chronic Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV)-1 Coinfection
Condition: Hepatitis C Virus Infection
Intervention: Drug: SOF/GS-5816
33 Active, not recruiting Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination for 8 Weeks in Subjects With Chronic Genotype 1 HCV and HIV-1 Co-infection
Condition: Treatment of Hepatitis C
Intervention: Drug: Ledipasvir/Sofosbuvir FDC
34 Not yet recruiting Bone Mineral Density in Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Adult Subjects Switching From a Tenofovir Regimen to a Dolutegravir Plus Rilpivirine Regimen
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: Subjects do not receive study medication in this study 202094
35 Not yet recruiting Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Cabotegravir tablet 30 mg once daily for 28 days.;   Drug: Cabotegravir injection 400 mg/2mL (2 x 400 mg split injection) IM given once on Day 1.
36 Recruiting Efficacy of VHM After Treatment Interruption in Subjects Initiating ART During Acute HIV Infection
Condition: Acute HIV Infection
Interventions: Drug: Vorinostat;   Drug: Hydroxychloroquine;   Drug: Maraviroc;   Drug: Tenofovir;   Drug: Emtricitabine;   Drug: Efavirenz;   Drug: Darunavir
37 Active, not recruiting The Effect of Antacids on the Pharmacokinetics (PK) of Raltegravir in Human Immunodeficiency Virus (HIV)-Infected Participants (MK-0518-824)
Condition: HIV Infection
Interventions: Drug: Raltegravir 1200 mg;   Drug: TUMS;   Drug: Leader Antacid
38 Recruiting VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption
Condition: HIV
Intervention: Biological: VRC-HIVMAB060-00-AB (VRC01)
39 Recruiting Acute Partner and Social Contact Referral: iKnow
Conditions: Acute HIV Infection;   HIV Seropositive;   Sexually Transmitted Infections
Intervention: Other: Notification cards
40 Recruiting Improving Adherence Among HIV+ Rwandan Youth: A TI-CBTe Indigenous Leader Model
Condition: Human Immunodeficiency Virus
Intervention: Behavioral: Trauma-Informed Cognitive Behavioral Therapy enhanced (TI-CBTe)

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years